Skip to main content

Bancel Stephane's Form 4 filing

Moderna, Inc. (MRNA) · filed Jan 27, 2023

Accession no.
0001127602-23-002450
Filed
Jan 27, 2023
Trade date
Jan 25-26, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 12 non-derivative transactions and 2 derivative transactions. Open-market sales total $15.3M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bancel StephaneCIK 0001443340Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 25, 2023Common StockMOption exerciseAcquired+40,000$0.99+$39,6005,451,946Direct
Jan 25, 2023Common StockSSaleDisposed−6,790$190.65F2−$1,294,513.55,445,156Direct
Jan 25, 2023Common StockSSaleDisposed−6,260$191.51F3−$1,198,852.65,438,896Direct
Jan 25, 2023Common StockSSaleDisposed−19,850$192.32F4−$3,817,5525,419,046Direct
Jan 25, 2023Common StockSSaleDisposed−7,100$193.39F5−$1,373,0695,411,946Direct
Jan 26, 2023Common StockMOption exerciseAcquired+40,000$0.99+$39,6005,451,946Direct
Jan 26, 2023Common StockSSaleDisposed−4,295$188.09F6−$807,846.555,447,651Direct
Jan 26, 2023Common StockSSaleDisposed−3,835$189.21F7−$725,620.355,443,816Direct
Jan 26, 2023Common StockSSaleDisposed−8,823$190.27F8−$1,678,752.215,434,993Direct
Jan 26, 2023Common StockSSaleDisposed−15,847$191.08F9−$3,028,044.765,419,146Direct
Jan 26, 2023Common StockSSaleDisposed−3,289$192.16F10−$632,014.245,415,857Direct
Jan 26, 2023Common StockSSaleDisposed−3,911$192.92F11−$754,510.125,411,946Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 25, 2023Common StockMOption exerciseDisposed−40,000$0.00$01,747,155Direct
Jan 26, 2023Common StockMOption exerciseDisposed−40,000$0.00$01,707,155Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $189.92 to $190.92. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $190.94 to $191.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $191.95 to $192.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $192.96 to $193.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $187.62 to $188.54. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $188.64 to $189.63. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $189.65 to $190.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $190.66 to $191.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $191.67 to $192.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $192.68 to $193.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)